Skip to news
JQJO
Latest

Rare Ocular Melanoma Spurs Treatment, Advocacy | JQJO

Rare Ocular Melanoma Spurs Treatment, Advocacy

Rare Ocular Melanoma Spurs Treatment, Advocacy

Tap title to read story

0:00 / 0:42

After intermittent left-eye pain, Allison Dashow was ultimately diagnosed with choroidal melanoma, a rare eye cancer affecting six in one million Americans annually. A second opinion led her to plaque brachytherapy on June 30, 2022; six months later, doctors deemed the tumor dead and she remains NED, though she now manages radiation retinopathy with injections every five weeks. As she raises awareness and leans on the Melanoma Research Foundation community, Dashow will receive the group’s Courage Award this month; interventional radiologist Dr. Tate Kirk will also be honored for work with metastatic cases.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Bears Return From Bye Week

Tap title to read story

0:00 / 0:00

JQJO

Find your next story

Search JQJO’s current coverage.